ADHD: The Science of Mind Evolves
Good Morning! – to a new ADHD world with more treatment options coming this fall. I just replied to a previous comment regarding the use of Tenex, guanfacine, [previously identified as helpful for tic disorder], and will send out this brief note with an interesting reference worth reading.
Short note, new vocabulary, take a moment sometime this week to chase down these links – they will likely soon become part of your everyday thinking in ADHD treatment.
Let’s make this simple, – er, let’s try to make the basic pharmacology a bit more understandable. Best to start with the basics, and this article in Science Daily breaks down an interview with a neurophysiologist at Yale, Amy Arnsten PhD, who has been looking at alpha 2 adrenoreceptors for several years now.
I’ve heard Amy present this interesting material, and know it needs translation, so I will simplify this brief note for you -
The real value to this new formulation:
- New brain information takes us beyond simply thinking about the synapse – into brain networks, systems and our new friend: ion channels
- This medication is not a stimulant
- More interesting information about brain function arises from evidence – and appears to offer significant possibilities for ADHD treatment.
New Post
Heads up readers: Posted an even more precise post on Intuniv for ADHD: Dosing Details – Do pop over there if you find this topic of interest.
cp
Related articles by Zemanta
- Pump Your Brain–And Other Stories from MIND (scientificamerican.com)
- ADHD Medications: Neurotransmitters to the Rescue (corepsychblog.com)
- A non-controlled substance drug for ADHD: Intuniv (guanfacine) ER (medicineandtechnology.com)
- INTUNIV demonstrated symptom reduction on oppositional subscale Conners’ ADHD rating scale (scienceblog.com)

Digitally available now at Nook, Kindle, Barnes and Noble.
ADHD Medication Rules – PDF For Your Desktop
ADHD Medication Rules | Paying Attention To The Meds For Paying Attention – Kindle Version









